Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

By Basso D.   Fogar P.   Piva M.G.   Navaglia F.   Mazza S.   Prayer-Galetti T.   Castellucci E.   Pagano F.   Plebani M.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 710-715

Elsevier

Access to resources Recommend Favorite

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

By Djavan B.   Zlotta A.   Kratzik C.   Remzi M.   Seitz C.   Schulman C.C.   Marberger M.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 517-522

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy

By Tombal B.   Querton M.   de Nayer P.   Sauvage P.   Cosyns J.-P.   Feyaerts A.   Opsomer R.   Wese F.X.   Van Cangh P.J.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 256-260

Elsevier

Access to resources Recommend Favorite

Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

By Djavan B.   Shariat S.   Ghawidel K.   G   uven-Marberger K.   Remzi M.   Kovarik J.   Hoerl W.H.   Marberger M.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1169-1174

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

By Elabbady Ahmed   Khedr Mahrousa  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite